| Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention |
27 |
| Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
25 |
| ICRU report91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery |
16 |
| Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease |
16 |
| PhaseII study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer |
16 |
| Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO) |
14 |
| Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters |
12 |
| Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer A systematic review |
11 |
| Treatment planning for spinal radiosurgery |
11 |
| Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery |
11 |
| Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in apatient with NSCLC stage IIIb inducing long-term tumor control: acase study |
10 |
| PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue |
9 |
| Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial |
8 |
| Response rates and recurrence patterns after low-dose radiotherapy with 4Gy in patients with low-grade lymphomas |
8 |
| Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy |
8 |
| Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer |
8 |
| Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy |
8 |
| Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease: An individual patient data analysis of three clinical trials |
7 |
| SBRT planning for spinal metastasis: indications from alarge multicentric study |
7 |
| Socioeconomic status and quality of life in patients with locally advanced head and neck cancer |
7 |
| A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma |
6 |
| Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study |
6 |
| Chemoradiotherapy for anal cancer: are we as good as we think? |
6 |
| Rectal retractor application during image-guided dose-escalated prostate radiotherapy |
6 |
| Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries |
6 |
| Reirradiation plus hyperthermia for recurrent breast cancer en cuirasse |
6 |
| Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention |
6 |
| Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer |
6 |
| Quality of training in radiation oncology in Germany: where do we stand? Results from a 2016/2017 survey performed by the working group young DEGRO of the German society of radiation oncology (DEGRO) |
6 |
| Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy |
5 |
| Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold |
5 |
| Comparison of treatment plans for ahigh-field MRI-linac and aconventional linac for esophageal cancer |
5 |
| Hyperthermic chest wall re-irradiation in recurrent breast cancer: aprospective observational study |
5 |
| Radiotherapy of epicondylitis humeri: Analysis of 138 elbows treated with alinear accelerator |
5 |
| Is low dose radiotherapy an effective treatment for Baker's cyst? |
5 |
| Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy Results from a large multicenter cohort |
5 |
| Patterns of relapse as determined by Ga-68-PSMA ligand PET/CT after radical prostatectomy Importance for tailoring and individualizing treatment |
5 |
| Oligometastases in prostate cancer Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT |
5 |
| Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy |
5 |
| Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus |
5 |
| Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients |
5 |
| Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics |
5 |
| Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer |
5 |
| Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy |
5 |
| Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients |
5 |
| Comparison of Ga-68-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer |
5 |
| Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients: Amono-institutional experience on 110 brain metastases |
5 |
| Prospective feasibility analysis of a novel off-line approach for MR-guided radiotherapy |
5 |
| Radiation-induced carotid artery lesions |
5 |
| Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy |
5 |
